Publication for CD48 and ITGAL
| Species | Symbol | Function* | Entrez Gene ID* | Other ID | Gene coexpression |
CoexViewer |
|---|---|---|---|---|---|---|
| hsa | CD48 | CD48 molecule | 962 | [link] | ||
| hsa | ITGAL | integrin subunit alpha L | 3683 |
| Pubmed ID | Priority | Text |
|---|---|---|
| 29543389 | 0.95 | CD11a- EPCR+ CD150+ CD48-. |
| 0.85 | CD11a-EPCR+; "Not SLAM" = not CD150+CD48-. | |
| 0.74 | CD48-, and thus there are likely non-HSCs within the CD11a- EPCR+ fraction. | |
| 0.52 | CD11a- EPCR+ (11a/EPCR) to Ter119- CD27+ Kit+ Sca-1+ CD34- CD150+ CD48- (SLAMKLS34). | |
| 16203869 | 0.93 | CD48 (CD16, LFA-1, and 2B4, respectively) in isolation was not sufficient to induce strong cytotoxicity by resting NK cells. |
| 23858032 | 0.89 | CD48, PVR, 4-1BB, ICAM-1, CD69, CLTA-4, CD11a, and CD90. |
| 24489840 | 0.88 | CD48, Fas-L and LFA-1 increased and expression of CD49d and NKG2D decreased on CBCD34+-NK cells (P<0.05, Figures S10 and S11). |
| 27086912 | 0.58 | CD48, CD58, CD44, CD38, CD6, CD97, Fas/CD95, LFA-1 and beta2-integrin. |
| 27573813 | 0.56 | CD48, we obtained evidence that 2B4-mediated inhibition was accompanied by decreased induction of the activated form of LFA-1, as suggested by reactivity with the anti-LFA-1 mAb m24. |
The preparation time of this page was 0.1 [sec].
